Meridian Bioscience (VIVO) Tops Q4 EPS by 4c, Revenue Beat; Offers FY19 EPS Guidance Below Consensus
Go back to Meridian Bioscience (VIVO) Tops Q4 EPS by 4c, Revenue Beat; Offers FY19 EPS Guidance Below Consensus| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 4.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.75 | 52 Week High | $21.49 | |||
| Open | $4.75 | 52 Week Low | $15.75 | |||
| Day High | $4.75 | P/E | 5.40 | |||
| Day Low | $4.75 | EPS | $0.88 | |||
| Volume | 41,286 | |||||
